InsiderSource
VCYT

VERACYTE, INC.

SEC CIK 1384101
$47.33 +31.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$9.88M
10 open-market
Net insider flow
−$9.88M
Net selling
Filings shown
120
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at VCYT have sold a net $9.88M of stock (0 open-market buys vs 10 sells).

Largest recent trade: Stapley Marc sold $6.92M of VCYT, trimming their stake 24%.

Most active filer: Hanna John Walter Jr, with 19 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for VCYT, newest first
View on SEC EDGAR ↗
VCYT
VERACYTE, INC.
Sell Leite John · Chief Commercial Officer-CLIA · Open-market sale · filed Mar 10, 2025 ΔOwn −2.2%

Leite John sold $74.5K of VCYT, trimming their stake 2%.

−$74.5K
2,400 sh @ $31
VCYT
VERACYTE, INC.
Sell Leite John · Chief Commercial Officer-CLIA · Open-market sale · filed Mar 10, 2025 ΔOwn −4.8%

Leite John sold $160.1K of VCYT, trimming their stake 5%.

−$160.1K
5,011 sh @ $32
VCYT
VERACYTE, INC.
Sell Febbo Phillip G. · Chief Scientific & Med Officer · Open-market sale · filed Mar 6, 2025 ΔOwn −4.9%

Febbo Phillip G. sold $146.8K of VCYT, trimming their stake 5%.

−$146.8K
4,467 sh @ $33
VCYT
VERACYTE, INC.
Sell Febbo Phillip G. · Chief Scientific & Med Officer · Open-market sale · filed Mar 6, 2025 ΔOwn −4.1%

Febbo Phillip G. sold $121.2K of VCYT, trimming their stake 4%.

−$121.2K
3,570 sh @ $34
VCYT
VERACYTE, INC.
Sell Stapley Marc · Director, Chief Executive Officer · Open-market sale · filed Mar 6, 2025 ΔOwn −8.8%

Stapley Marc sold $925.2K of VCYT, trimming their stake 9%.

−$925.2K
28,189 sh @ $33
Advertisement
VCYT
VERACYTE, INC.
Sell Stapley Marc · Director, Chief Executive Officer · Open-market sale · filed Mar 6, 2025 ΔOwn −8.0%

Stapley Marc sold $794K of VCYT, trimming their stake 8%.

−$794K
23,414 sh @ $34
VCYT
VERACYTE, INC.
Sell Stapley Marc · Director, Chief Executive Officer · Open-market sale · filed Mar 6, 2025 ΔOwn −0.4%

Stapley Marc sold $37.6K of VCYT.

−$37.6K
1,094 sh @ $34
VCYT
VERACYTE, INC.
Sell McGuire Annie · SVP, General Counsel · Open-market sale · filed Mar 6, 2025 ΔOwn −1.6%

Mcguire Annie sold $38.5K of VCYT, trimming their stake 2%.

−$38.5K
1,142 sh @ $34
VCYT
VERACYTE, INC.
Sell Leite John · Chief Commercial Officer-CLIA · Open-market sale · filed Mar 3, 2025 ΔOwn −6.8%

Leite John sold $194.4K of VCYT, trimming their stake 7%.

−$194.4K
5,746 sh @ $34
VCYT
VERACYTE, INC.
Sell Chambers Rebecca · Chief Financial Officer · Open-market sale · filed Feb 5, 2025 ΔOwn −0.5%

Chambers Rebecca sold $23.1K of VCYT.

−$23.1K
527 sh @ $44
VCYT
VERACYTE, INC.
Sell Stapley Marc · Director, Chief Executive Officer · Open-market sale · filed Dec 17, 2024 ΔOwn −1.7%

Stapley Marc sold $225.1K of VCYT, trimming their stake 2%.

−$225.1K
5,190 sh @ $43
VCYT
VERACYTE, INC.
Sell Stapley Marc · Director, Chief Executive Officer · Open-market sale · filed Dec 17, 2024 ΔOwn −0.1%

Stapley Marc sold $17.7K of VCYT.

−$17.7K
400 sh @ $44
VCYT
VERACYTE, INC.
Sell Febbo Phillip G. · Chief Scientific & Med Officer · Open-market sale · filed Dec 6, 2024 ΔOwn −4.6%

Febbo Phillip G. sold $173.4K of VCYT, trimming their stake 5%.

−$173.4K
3,934 sh @ $44
VCYT
VERACYTE, INC.
Sell McGuire Annie · SVP, General Counsel · Open-market sale · filed Dec 6, 2024 ΔOwn −20%

Mcguire Annie sold $823.2K of VCYT, trimming their stake 20%.

−$823.2K
18,699 sh @ $44
VCYT
VERACYTE, INC.
Sell Leite John · Chief Commercial Officer-CLIA · Open-market sale · filed Dec 4, 2024 ΔOwn −1.4%

Leite John sold $45.4K of VCYT, trimming their stake 1%.

−$45.4K
1,050 sh @ $43
VCYT
VERACYTE, INC.
Sell Chambers Rebecca · Chief Financial Officer · Open-market sale · filed Dec 4, 2024 ΔOwn −5.8%

Chambers Rebecca sold $302.6K of VCYT, trimming their stake 6%.

−$302.6K
7,000 sh @ $43
VCYT
VERACYTE, INC.
Sell Wygant Jonathan · VP, Chief Accounting Officer · Open-market sale · filed Dec 4, 2024 ΔOwn −2.3%

Wygant Jonathan sold $41.5K of VCYT, trimming their stake 2%.

−$41.5K
956 sh @ $43
VCYT
VERACYTE, INC.
Sell Wygant Jonathan · VP, Chief Accounting Officer · Open-market sale · filed Nov 29, 2024 ΔOwn −11%

Wygant Jonathan sold $215.8K of VCYT, trimming their stake 11%.

−$215.8K
5,032 sh @ $43
VCYT
VERACYTE, INC.
Sell Chambers Rebecca · Chief Financial Officer · Open-market sale · filed Nov 14, 2024 ΔOwn −11%

Chambers Rebecca sold $585.7K of VCYT, trimming their stake 11%.

−$585.7K
15,275 sh @ $38
VCYT
VERACYTE, INC.
Sell EPSTEIN ROBERT S · Director · Open-market sale · filed Nov 14, 2024 ΔOwn −25%

Epstein Robert S sold $574.8K of VCYT, trimming their stake 25%.

−$574.8K
15,000 sh @ $38
VCYT
VERACYTE, INC.
Sell Leite John · Chief Commercial Officer-CLIA · Open-market sale · filed Sep 6, 2024 ΔOwn −6.7%

Leite John sold $163.2K of VCYT, trimming their stake 7%.

−$163.2K
5,479 sh @ $30
VCYT
VERACYTE, INC.
Sell Leite John · Chief Commercial Officer-CLIA · Open-market sale · filed Jul 18, 2024 ΔOwn −1.5%

Leite John sold $31.9K of VCYT, trimming their stake 2%.

−$31.9K
1,277 sh @ $25
VCYT
VERACYTE, INC.
Sell Bhanji Muna · Director · Open-market sale · filed Jun 11, 2024 ΔOwn −14%

Bhanji Muna sold $78.6K of VCYT, trimming their stake 14%.

−$78.6K
3,870 sh @ $20
VCYT
VERACYTE, INC.
Sell Bhanji Muna · Director · Open-market sale · filed May 30, 2024 ΔOwn −5.4%

Bhanji Muna sold $32.3K of VCYT, trimming their stake 5%.

−$32.3K
1,539 sh @ $21
VCYT
VERACYTE, INC.
Sell Bhanji Muna · Director · Open-market sale · filed Jun 21, 2023 ΔOwn −17%

Bhanji Muna sold $153.1K of VCYT, trimming their stake 17%.

−$153.1K
5,793 sh @ $26
VCYT
VERACYTE, INC.
Sell Bhanji Muna · Director · Open-market sale · filed Jun 21, 2023 ΔOwn −0.3%

Bhanji Muna sold $2.7K of VCYT.

−$2.7K
100 sh @ $27
VCYT
VERACYTE, INC.
Sell Bhanji Muna · Director · Open-market sale · filed Jun 1, 2023 ΔOwn −5.9%

Bhanji Muna sold $39.9K of VCYT, trimming their stake 6%.

−$39.9K
1,539 sh @ $26
VCYT
VERACYTE, INC.
Buy Stapley Marc · Director, Chief Executive Officer · Open-market purchase · filed Jun 13, 2022 ΔOwn +60%

Stapley Marc, VCYT's CEO, spent $980.1K of their own money on 60,000 shares at $16, growing their stake 60%.

+$980.1K
60,000 sh @ $16
VCYT
VERACYTE, INC.
Sell Hanna John Walter JR · Chief Commercial Officer · Open-market sale · filed Nov 9, 2020 ΔOwn −21%

Hanna John Walter Jr sold $870.1K of VCYT, trimming their stake 21%.

−$870.1K
20,050 sh @ $43
VCYT
VERACYTE, INC.
Sell Hanna John Walter JR · Chief Commercial Officer · Open-market sale · filed Nov 9, 2020 ΔOwn −1.6%

Hanna John Walter Jr sold $53K of VCYT, trimming their stake 2%.

−$53K
1,200 sh @ $44
Advertisement

About VCYT insider activity

This page tracks every recent Form 4 filed for VERACYTE, INC. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is VCYT insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for VERACYTE, INC. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.